Centre for Evidence in Transplantation :: About Us :: Current Staff:: Philip Macklin

Philip Macklin

Research Fellow

Philip attended Edinburgh Medical School were he graduated with an honours degree in Medical Biology in 2006 and in Clinical Medicine in 2009. His research focuses on the role of Rituximab as an immunosuppressant in renal transplantation.

His dissertation was awarded an MSc in Surgical Sciences with distinction jointly from the Royal College of Surgeons and the University of Edinburgh in June 2012. He is now preparing manuscripts from his work for publication.

Philip is now training as a pathologist. Outside of medicine he enjoys reading, cinema and many sports, especially rugby, cricket and football.

Publications

Macklin PS, Morris PJ, Knight SR. A systematic review of the use of rituximab for the treatment of antibody-mediated renal transplant rejection. Transplantation Reviews 2017; 31(2): 87-95. [PMID:28187998]

Macklin PS, Morris PJ, Knight SR. A systematic review of the use of rituximab as induction therapy in renal transplantation. Transplant Rev. 2015; 29(2):103-8. [PMID:25555541]

MacKlin P, Morris PJ and Knight SR. A Systematic Review of the Use of Rituximab for Desensitization in Renal Transplantation. Transplantation 2014; 98(8):794-805 [PMID:25321163]

Macklin P,Knight S, Morris P. A systematic review of rituximab as desensitisation therapy in renal transplantation. (Poster presentation at the Joint British Transplantation Society and Renal Association Congress, Bournemouth, March 2013)